Intervention Protocol

You have free access to this content

Statins for preventing colorectal adenoma and carcinoma

  1. Dipika Bansal1,*,
  2. Kapil Gudala2,
  3. Krishna Undela3

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 30 MAY 2014

DOI: 10.1002/14651858.CD011137


How to Cite

Bansal D, Gudala K, Undela K. Statins for preventing colorectal adenoma and carcinoma (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD011137. DOI: 10.1002/14651858.CD011137.

Author Information

  1. 1

    National Institute of Pharmaceutical Education and Research (NIPER), Clinical Research Unit, Department of Pharmacy Practice, Mohali, Punjab, India

  2. 2

    National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmacy Practice, Mohali, Punjab, India

  3. 3

    JSS College of Pharmacy, JSS University, Department of Pharmacy Practice, Mysore, Karnataka, India

*Dipika Bansal, Clinical Research Unit, Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), F-307, Research Block, NIPER, Sector 67, Mohali, Punjab, 160062, India. dipikabansal079@gmail.com. dipikabansal@niper.ac.in.

Publication History

  1. Publication Status: New
  2. Published Online: 30 MAY 2014

SEARCH

References

Additional references

ALLHAT 2002
  • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). Journal of the American Medical Association 2002;288(23):2998-3007. [PUBMED: 12479764]
American Cancer Society 2013
  • American Cancer Society. Survival rates for colorectal cancer. http://www.cancer.org/cancer/colonandrectumcancer/overviewguide/colorectal-cancer-overview-survival-rates [accessed 14 January 2014].
Blais 2000
  • Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Archives of Internal Medicine 2000;160(15):2363-8. [PUBMED: 10927735]
Cafforio 2005
  • Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005;26(5):883-91. [PUBMED: 15705602]
Colhoun 2004
  • Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364(9435):685-96. [PUBMED: 15325833]
Coogan 2007
Coogan 2007a
Demierre 2005
Edwards 1999
Farwell 2008
  • Farwell WR, Scranton RE, Lawler EV, Lew RA, Brophy MT, Fiore LD, et al. The association between statins and cancer incidence in a veterans population. Journal of the National Cancer Institute 2008;100(2):134-9. [PUBMED: 18182618]
Flick 2009
  • Flick ED, Habel LA, Chan KA, Haque R, Quinn VP, Van Den Eeden SK, et al. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs 2009;69(11):1445-57. [PUBMED: 19634923]
Friis 2005
GLOBOCAN 2012
  • International Agency for Research on Cancer. GLOBOCAN 2012. http://globocan.iarc.fr/ [accessed January 2014].
Graaf 2004
  • Graaf MR, Richel DJ, van Noorden CJ, Guchelaar HJ. Effects of statins and farnesyl transferase inhibitors on the development and progression of cancer. Cancer Treatment Reviews 2004;30(7):609-41. [PUBMED: 15531395]
Graaf 2004a
Haukka 2010
Higgins 2002
Hoffmeister 2007
Jacobs 2006
  • Jacobs EJ, Rodriguez C, Brady KA, Connell CJ, Thun MJ, Calle EE. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. Journal of the National Cancer Institute 2006;98(1):69-72. [PUBMED: 16391373]
Kaye 2004
Kelly 1992
  • Kelly CP, O'Keane JC, Orellana J, Schroy PC, Yang S, LaMont JT, et al. Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. American Journal of Physiology 1992;263(6 Pt 1):G864-70. [PUBMED: 1362041]
Keyomarsi 1991
  • Keyomarsi K, Sandoval L, Band V, Pardee AB. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Research 1991;51(13):3602-9. [PUBMED: 1711413]
Kinzler 1996
Krook 1991
  • Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. The New England Journal of Medicine 1991;324(11):709-15. [PUBMED: 1997835]
Liao 2005
LIPID Study 2002
  • LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease). Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet 2002;359(9315):1379-87. [PUBMED: 11978335]
Mariotto 2011
  • Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. Journal of the National Cancer Institute 2011;103(2):117-28. [PUBMED: 21228314]
Maroun 2003
  • Maroun J, Ng E, Berthelot JM, Le Petit C, Dahrouge S, Flanagan WM, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Diseases in Canada 2003;24(4):91-101. [PUBMED: 14733758]
Mo 2004
  • Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Experimental Biology and Medicine 2004;229(7):567-85. [PUBMED: 15229351]
Moertel 1990
  • Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. The New England Journal of Medicine 1990;322(6):352-8. [PUBMED: 2300087]
Nakamura 2006
  • Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006;368(9542):1155-63. [PUBMED: 17011942]
Poynter 2005
Rao 1999
  • Rao S, Porter DC, Chen X, Herliczek T, Lowe M, Keyomarsi K. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proceedings of the National Academy of Sciences of the United States of America 1999;96(14):7797-802. [PUBMED: 10393901]
Rasool 2013
  • Rasool S, Kadla SA, Rasool V, Ganai BA. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumour Biology 2013;34(5):2469-76. [PUBMED: 23832537]
Ridker 2008
  • Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AMJ, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine 2008;359(21):2195-207. [PUBMED: 18997196]
Sacks 1996
  • Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. The New England Journal of Medicine 1996;335(14):1001-9. [PUBMED: 8801446]
Schachter 2004
Setoguchi 2007
Shepherd 1995
  • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine 1995;333(20):1301-7. [PUBMED: 7566020]
Shepherd 2002
  • Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360(9346):1623-30. [PUBMED: 12457784]
Singh 2009
  • Singh H, Mahmud SM, Turner D, Xue L, Demers AA, Bernstein CN. Long-term use of statins and risk of colorectal cancer: a population-based study. The American Journal of Gastroenterology 2009;104(12):3015-23. [PUBMED: 19809413]
Sleijfer 2005
Strandberg 2004
  • Strandberg TE, Pyorala K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G, et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004;364(9436):771-7. [PUBMED: 15337403]
Vinogradova 2007
  • Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study. Gastroenterology 2007;133(2):393-402. [PUBMED: 17681160]
Weitz-Schmidt 2001
  • Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Medicine 2001;7(6):687-92. [PUBMED: 11385505]
Winawer 1999
Yang 2008